Investigational New Drug (IND)/ Investigational Device Exemption (IDE) Regulatory Program

Institutional Policy

Under the Johns Hopkins University Investigator-held INDs/IDEs Policy (GEN013), investigators planning to hold a new IND or IDE must complete Sponsor-Investigator qualification and obtain OCT authorization for each new application before FDA submission.

For additional information, review the IND/IDE Policy FAQs.

Get Started

Sponsor-Investigator Qualification

  • One-time requirement
  • Obtain OCT approval to serve as an IND/IDE Sponsor-Investigator.

View Qualification Requirements and Apply

Planning Phase Application

  • Required for each new IND/IDE application
  • Obtain institutional authorization before submitting a new IND or IDE application to the FDA.

View Planning Phase Requirements and Instructions

FDA Submissions and Ongoing Responsibilities

  • Find guidance and resources for preparing FDA submissions and maintaining investigator-held INDs and IDEs.

View Active Submission | Johns Hopkins Medicine and Templates and Forms

Johns Hopkins University "JHU" Investigator-held IND/IDE Review Procedures

An Investigator-held IND/IDE Review Procedures Overview flowchart is available.

Regulatory Resources

To support high-quality regulatory submissions, improve efficiency, and help minimize approval delays and potential risks, we encourage teams to connect with a representative from the IND/IDE Regulatory Program before submitting to the FDA. For support, please email us at  [email protected] to schedule a consultation.

Education and Training

The following training must be completed through myLearning by all JHU faculty who will be new IND/IDE holders.